Similar articles

• Understanding epoetin use: databases or clinical trials?

  Roger SD. Roger SD. Nephrology (Carlton). 2007 Apr;12(2):118-9. doi: 10.1111/j.1440-1797.2007.00768.x. Nephrology (Carlton). 2007. PMID: 17371331 No abstract available.
• [Advances in therapy of renal anemia: darbepoetin alfa].

  Schaefer R. Schaefer R. Wien Klin Wochenschr. 2002 Dec 30;114(23-24):955-7. Wien Klin Wochenschr. 2002. PMID: 12635460 German. No abstract available.
• Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.

  Ongkingco JR, Ruley EJ, Turner ME, Fragale MR. Ongkingco JR, et al. Am J Nephrol. 1994;14(1):14-8. doi: 10.1159/000168680. Am J Nephrol. 1994. PMID: 8017476
• [Current issues in erythropoietin therapy of renal anemia].

  Zakar G. Zakar G. Lege Artis Med. 2007 Oct;17(10):667-73. Lege Artis Med. 2007. PMID: 19227596 Review. Hungarian.
• Erythropoietin therapy in patients with chronic renal failure.

  Pinevich AJ, Petersen J. Pinevich AJ, et al. West J Med. 1992 Aug;157(2):154-7. West J Med. 1992. PMID: 1441466 Free PMC article. Review.